Pironi et al., 2003 - Google Patents
Peroxidation potential of lipid emulsions after compounding in all-in-one solutionsPironi et al., 2003
- Document ID
- 1968434843944332101
- Author
- Pironi L
- Guidetti M
- Zolezzi C
- Fasano M
- Paganelli F
- Merli C
- Bersani G
- Pizzoferrato A
- Miglioli M
- Publication year
- Publication venue
- Nutrition
External Links
Snippet
OBJECTIVE: We investigated the peroxidation potential of fat emulsions in all-in-one solutions (AIOs). METHODS: Three 20% emulsions were compared: soybean oil (SO; 60% polyunsaturated fatty acids [PUFAs], α-tocopherol: PUFAs= 0.44), soybean plus medium …
- 239000002960 lipid emulsion 0 title abstract description 44
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. cannabinols, methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A61K31/355—Tocopherols, e.g. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K8/00—Cosmetic or similar toilet preparations
- A61K8/18—Cosmetic or similar toilet preparations characterised by the composition
- A61K8/30—Cosmetic or similar toilet preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/676—Ascorbic acid, i.e. vitamin C
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Pironi et al. | Peroxidation potential of lipid emulsions after compounding in all-in-one solutions | |
| Neve et al. | 6 Selenium deficiency | |
| Lavoie et al. | Admixture of a multivitamin preparation to parenteral nutrition: the major contributor to in vitro generation of peroxides | |
| Carr et al. | Does vitamin C act as a pro‐oxidant under physiological conditions? | |
| Johnston et al. | Ascorbic acid | |
| Chen et al. | Dietary sesame reduces serum cholesterol and enhances antioxidant capacity in hypercholesterolemia | |
| Kim et al. | Antioxidant capacities of α-tocopherol, trolox, ascorbic acid, and ascorbyl palmitate in riboflavin photosensitized oil-in-water emulsions | |
| Mobarhan et al. | Effects of β‐carotene repletion on β‐carotene absorption, lipid peroxidation, and neutrophil superoxide formation in young men | |
| JP2011144186A (en) | Composition comprising nadh/nadph | |
| KR20060100402A (en) | Composition containing reduced coenzyme q | |
| Lemoyne et al. | Plasma vitamin E and selenium and breath pentane in home parenteral nutrition patients | |
| Tauler et al. | Supplementation with an antioxidant cocktail containing coenzyme Q prevents plasma oxidative damage induced by soccer | |
| Ouchi et al. | Kinetic study of the antioxidant activity of pyrroloquinolinequinol (PQQH2, a reduced form of pyrroloquinolinequinone) in micellar solution | |
| US5258179A (en) | Protection of a food, cosmetic or pharmaceutical product against oxidation | |
| Takebayashi et al. | Inhibition of free radical-induced erythrocyte hemolysis by 2-O-substituted ascorbic acid derivatives | |
| Cheng et al. | Effects of multinutrient supplementation on antioxidant defense systems in healthy human beings | |
| Blakely et al. | Canthaxanthin and excess vitamin A alter α-tocopherol, carotenoid and iron status in adult rats | |
| Akobeng et al. | Effect of exclusive enteral nutritional treatment on plasma antioxidant concentrations in childhood Crohn's disease | |
| Meltzer et al. | Supplementary selenium influences the response to fatty acid-induced oxidative stress in humans | |
| EP0424679B1 (en) | Protection of a food product, a cosmetic product or a pharmaceutical product against oxydation | |
| De Bree et al. | Evidence for a protective (synergistic?) effect of B-vitamins and omega-3 fatty acids on cardiovascular diseases | |
| Tamai et al. | Hemolysis and membrane lipid changes induced by xanthine oxidase in vitamin E deficient red cells | |
| Kamal-Eldin | Antioxidative activity of vitamin E | |
| Vora Axita et al. | Analysis of antioxidants and its properties of vitamins as a key source for human health | |
| Guidetti et al. | Vitamin A and vitamin E isoforms stability and peroxidation potential of all-in-one admixtures for parenteral nutrition |